The Causes of Early Deterioration in Renal Function Following Successful Renal Interventions

Bibliography

• Harden P. N., MacLeod M. J., Rodger R. S. C. et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet, 1997, 349: 1133–1136.
   Google Scholar
• Shannon H. M., Gillespie I. N., Moss J. G. Salvage of the solitary kidney by insertion of a renal artery stent. American Journal of Roentgenology, 1998, 171: 217–222.
   Google Scholar
• Ivanovic V., McKusick M. A., Johnson C. M. et al. Renal artery stent placement: complications at a single tertiary care center. Journal of Vascular & Interventional Radiology, 2003, 14: 21725.
   Google Scholar
• Henry M., Klonaris C., Henry I. et al. Protected Renal Stenting with the PercuSurge Guard Wire device: a pilot study. Journal of Endovascular Therapy, 2001, 8: 227–237.
   Google Scholar
• Tepel M., van der Giet M., Schwarzfeld C. et al. Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine. NEJM, 2000, 343: 180–184.
   Google Scholar
• Moss J. G. Ch 13: Renal and Visceral Artery Intervention. In Dyet, Ettles and Nicholson, Textbook of Endovascular Procedures (Pub: Churchill Livingstone, 2000).
   Google Scholar
• Henry M., Amor M., Henry I. et al. Stents in the treatment of Renal Artery Stenosis: long term follow up. Journal of Endovascular Surgery, 1999, 6: 42–51.
   Google Scholar
• Henry M., Amor M., Henry I. et al. Stent placement in the renal artery: three year experience with the Palmatz stent. JVIR, 1996, 7: 343–50.
   Google Scholar
• Gruberg L., Mintz G. S., Mehran R. et al. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre existing chronic renal insufficiency. JACC, 2000, 36: 1542–1548.
   Google Scholar
• Thurlbeck W. M., Castleman B. Atheromatous emboli to the kidneys after aortic surgery. New England Journal of Medicine, 1957, 257: 442–447.
   Google Scholar
• Flory C. M. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. American Journal of Pathology, 1945, 21: 549–565.
   Google Scholar
• Ramirez G., O’Neill W. M., Lambert R. et al. Cholesterol Embolization: A complication of angiography. Arch Intern Med, 1978, 138: 1430.
   Google Scholar
• Rapp J. H., Pan X. M., Sharp F. R. et al. Atheroemboli to the brain: size threshold for causing acute neuronal cell death. Journal of Vascular Surgery, 2000, 32: 68–76.
   Google Scholar
• Kimura M., Suzuki T., Hishida A. A rat model of progressive chronic renal failure produced by microembolism. American Journal of Pathology, 1999, 155: 1371–1380.
   Google Scholar
• Jordan W. D., Voellinger D. C., Doblar D. D., Plyushcheva N. P., Fisher W. S., McDowell H. A. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovascular Surgery, 1999, 7: 33–38.
   Google Scholar
• Al-Hamali S., Baskervile P., Fraser S., Walters H., Markus H. S. Detection of distal emboli in patients with peripheral arterial stenosis before and after iliac angioplasty. Journal of Vascular Surgery, 1999, 29: 345–351.
   Google Scholar
• Baim D. S., Wahr D., George B. et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 2002, 105: 1285–1290.
   Google Scholar
• Harkonan S., Kjellstrand C. M. Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med, 1977, 63: 939–946.
   Google Scholar
• Cruz C., Hricak H., Samhouri F. et al. Contrast media for Angiography: effect on renal function. Radiology, 1986, 158: 109–112.
   Google Scholar
• Hou S. H., Bushinsky D. A., Wish J. B. et al. Hospital acquired renal insufficiency: a prospective study. Am J Med, 1983, 74: 243–248.
   Google Scholar
• Luft V., Hoogestraat-Luft L., Fels L. M. et al. Contrast Media Nephropathy: Intravenous CT Angiography vs Intra-arterial Digital subtraction Angiography in Renal Artery stenosis: a Prospective Randomized Trial. Am J Kid Dis, 2002, 40: 236–242.
   Google Scholar
• Barrett B. J. Contrast nephrotoxicity. J Am Assoc Nephrologists, 1994, 5: 125–137.
   Google Scholar
• Diaz-Sandoval L. J., Kosowsky B. D., Losordo D. W. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). American Journal of Cardiology, 2002, 89: 356–358.
   Google Scholar
• Alaquaband S., Tumuluri R., Malik A. M. et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheterization & Cardiovascular Interventions, 2002, 57: 279–283.
   Google Scholar
• Durham J. D., Caputo C., Dokko J. et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Internationa, 2002, 62: 22022207.
   Google Scholar
• Briguori C., Manganelli F., Scarpato P. et al. Acetylcysteine and contrast agent-associated nephrotoxicity. Journal of the American College of Cardiology, 2002, 40: 298–303.
   Google Scholar
• Chamsuddin A. A., Kowalik K. J., Bjarnson H. et al. Using a dopamine 1A receptor agonist in high risk patients to ameliorate contrast associated nephropathy. AJR, 2002, 179: 591–596.
   Google Scholar
• Chalmers N., Jackson R. W. Comparison of Iodixanol and Iohexol in renal impairment. BJR, 1999, 72: 701–703.
   Google Scholar
• Aspelin P., Aubrey P., Fransson S. G. et al. Nephrotoxic effects in high risk patients undergoing angiography. N Engl J Med, 2003, 348: 491–499.
   Google Scholar